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Summary This study aimed to describe the prevalence and incidence of solar keratoses and skin cancers and
the natural history of solar keratoses in a random population sample. It was a cross-sectional study, with
follow-up, conducted in South Wales, and involved 1034 subjects aged 60 years and over drawn from the
Family Health Services Authority register. The main outcome measures were detection of the presence of solar
keratoses and skin cancers on sun-exposed skin and photographic validation of solar keratoses and biopsy
confirmation of cancers wherever possible. We found that solar keratosis prevalence was 23% (95% confidence
interval 19.5-26.5) and that of skin cancer (all types) 2% (95% confidence interval 1.0-3.5). The incidence
rate of solar keratoses was 149 lesions per 1000 person-years and of non-melanoma skin cancer 9 per 1000
person-years. In all 21% (95% CL 16-26) of solar keratoses regressed spontaneously during follow-up. None
underwent malignant change. We believe that the failure of individuals to seek medical advice and the variable
under-registration of non-melanoma skin cancer makes population-based study important. The high prevalence
and incidence of malignant and pre-malignant skin lesions in this random sample raise major public health
concerns. The high rate of spontaneous regression of solar keratoses and the low rate of malignant change
challenges conventional views about the need for routine treatment of these lesions.
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Skin cancer is currently the subject of detailed attention in
Britain. Identified by the government's Health of the Nation
Strategy on account of its rising incidence and apparently
high potential for prevention (Anonymous, 1992; Anon-
ymous 1993), additional concern has resulted from the
anticipated health effects of the thinning of the ozone layer.
The target of this strategy is to halt the year-on-year increase
in incidence of skin cancer by the year 2005,
There is strong evidence, based upon mortality and cancer
registration data that malignant melanoma (MM) has
become more common in many countries over the last 30
years (Streetly and Markowe, 1995; MacKie et al., 1985;
Popescu et al., 1990; Bonett et al., 1989; Elder, 1995).
However, trends in non-melanoma skin cancer (NMSC) are
less certain, largely because many cancer registers do not
include these tumours, and for those that do under-
ascertainment is a significant problem (Beadle et al., 1982).
Two Australian studies not based on cancer registers do,
however, indicate a recent increase in NMSC incidence (Giles
et al., 1988; Marks et al., 1993).
Despite the intense interest in skin cancer in Britain, the
basic descriptive and analytical epidemiology of NMSC and
solar keratoses (SK) - the latter being strong risk markers for
subsequent development of both NMSC and MM (Marks,
1995) - is very sparse (Harvey et al., 1989). Incident cases of
NMSC outnumber MM, which is more comprehensively
researched, by a factor of at least 8: 1 (Anonymous, 1993).
There has been only one truly population-based study of
NMSC and SK from Northern Europe published in recent
years (O'Beirn et al., 1968). All other studies have used
subjects seeking medical advice. These are inherently less
satisfactory, since the proportion of those with NMSC and
SKs who seek help is uncertain and the propensity to seek
medical advice may vary over time (Harvey et al., 1989).
Additionally, a number of hypothesised risk factors for
NMSC, such as Celtic ethnic origin, remain largely
uninvestigated (Lane-Brown et al., 1971; Marks, 1986).
Thinning of the ozone layer is occurring at 4% per decade
over northern latitudes (Armstrong, 1994) and threatens to
exacerbate the growing skin cancer problem. A 1% strato-
spheric ozone depletion should in theory lead to a 1.14%
increase in ground level ultraviolet radiation (UVR) at mid
latitudes, and a 1-3% increase in both non-melanoma and
melanoma skin cancers (Dahlback and Moan, 1990).
Pollution in the lower atmosphere may exert a partial
compensatory effect on UVR levels, however (Bruhl and
Crutzen, 1989).
In summary, there is a pressing need in the UK for
epidemiological investigation of NMSC and SKs in random
population samples in order to provide baseline data against
which the effectiveness of currently advocated preventive
measures may be judged, and to identify and confirm
hypothesised epidemiological risk factors.
The fieldwork for such a longitudinal study was performed
in South Glamorgan, in South Wales, between 1988 and
1992. The principal objectives of this study were:
(1) to describe the prevalence and incidence of SKs and skin
cancers in a random population sample;
(2) to describe the natural history of SKs;
(3) to identify risk markers for prevalent SKs and SCCs, for
incident SKs, and for spontaneous remission of SKs;
(4) to evaluate, using observational epidemiological meth-
ods, currently recommended preventive measures.
The first two objectives will be dealt with in this paper and
the third and fourth in a companion paper (Harvey et al.,
1996).
Methods
A random sample of 1034 subjects age 60 years and over
living in the county of South Glamorgan (total population
403 000) was drawn from the South Glamorgan Family
Health Services Authority (FHSA) register. Only a small
proportion of the elderly are not registered with a general
practitioner in the UK (Robert et al., 1995). Research ethics
committee approval was obtained.
A letter was sent to each subject's general practitioner
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asking if they had any objection to the inclusion of the
patient in the study. A brief explanatory letter was then sent
to each subject proposing a time when a research registrar in
dermatology would make a home visit. A tear-off slip and
reply-paid envelope were provided as well as a telephone
contact number. The registrar attempted to visit all those
who did not indicate unwillingness to participate. Several
attempts were made to contact subjects, involving further
house calls, letters and telephone calls.
At the visit a detailed administered questionnaire was
completed (seeking information about hypothesised risk
factors for NMSC and SKs) and an examination made of
the skin of the head and neck, arms (to the shoulder), legs
(below the knee) and feet. Polaroid photographs and 35 mm
slides were taken of suspected solar keratoses and skin
cancers. Given that over 80% of SKs (Frost and Green,
1994) and over 75% of NMSCs (Gallagher et al., 1990;
Chuang et al., 1990) occur on sun-exposed areas of the skin,
this limited skin examination gave a high probability of
detecting lesions with minimum disruption and embarrass-
ment for these elderly study subjects. The 35 mm slides were
later used to validate the diagnoses made by the registrar, by
projecting a random sample for a panel of three consultant
dermatologists who gave diagnoses independently of each
other. The GP of any patient with a suspected skin cancer was
contacted directly. Patients with SKs alone were reassured
that the lesion did not require immediate intervention but
would be assessed at a second visit. They were, however,
advised to consult their GP if lesions showed change.
Skin type was assessed by asking subjects how their skin
reacted after first unprotected exposure to the sun in spring/
early summer. Subjects were asked to recall their natural hair
colour at age 15 years. Cumulative UV exposure was assessed
by asking subjects to estimate their average outdoor exposure
(for weekdays and weekend days separately) during early
adult life (20-39 years), middle age (40-59 years) and old
age (60 years+). From this a cumulative number of hours of
UV exposure was calculated. This approach was based on
that used in previous epidemiological studies of skin cancer
(Graham et al., 1985) and takes account of the substantial
UV radiation exposure that can occur on cloudy days
(Marks, 1990). Skin colour was assessed by examining the
inner aspect of the upper arm, an area of skin which is
unlikely to be tanned.
A second, follow-up visit was made between one and two
years later. A second questionnaire was completed, including
questions about treatment received for any skin conditions
and lesions in the intervening period, and the same skin areas
were examined. New lesions were noted. The polaroid
photographs taken at the first visit were used as an aid in
determining whether SKs were new, persistent or had
resolved. Local pathology department records were scruti-
nised to determine the histological nature of any lesions
removed during the follow-up period. The patient's GP was
also contacted when pathology records failed to provide
information.
Information about skin type, hair colour at age 15 years
and estimated cumulative UV exposure was obtained on both
visits in order to examine the test-retest reliability of
subjects' responses.
Data were coded, entered and analysed using SPSS for
Windows version 6.
Sample size
The key measure used to determine the sample size was an
estimated prevalence of solar keratoses. Assuming a
prevalence of 10.6% (as found in a previous study in
Ireland, O'Beirn et al., 1968), and aiming to have 95%
confidence limits around this point estimate no wider than
+2.5%, required 580 subjects. Allowing for 20% non-
response and a further 20% for FHSA register inaccuracy
(Bickler et al., 1993), a random sample of 1034 subjects was
drawn from the register.
Statistical methods
Confidence intervals for proportions, prevalence and
incidence rates were determined using Confidence Interval
Analysis (CIA) version 1.1. Agreement for categorical data
was quantified using crude percentage agreement and
Cohen's kappa statistic (Altman, 1991). Cohen's kappa
provides a measure of agreement beyond that expected due
simply to chance.
Multiple logistic regression was used to determine factors
which were significant (P<0.05) independent predictors of
binary outcome variables (such as response/non-response).
Results
Response rates
Where there was positive evidence (a letter/telephone call, or
the original letter returned marked 'not known') that the
subject had moved away from the address or had died,
subjects were deemed to be unavailable to the study. A total
of 23.4% of subjects were not available at the outset of the
study (visit 1). Of those available, 70.7% (560) were seen at
visit 1. Of these 560 subjects, 12% became unavailable during
the follow-up period. Of those available for round 2, 79.3%
were seen. The mean (median) follow-up interval was 1.43
(1.40) years.
Data on address (including postcode), sex and age were
known for all subjects. Univariable analysis shows that round
1 non-responders were significantly more likely to be female,
older and living in the inner city, than responders. Analysis
by multiple logistic regression shows that these associations
remained after adjustment for each other. Adjusted odds
ratios (ORs) for response were: females vs males OR=0.70;
80+ years vs 60-64 years OR=0.58; inner city residence vs
other OR=0.45.
Non-responders in round 2 were more likely to be older,
but there was no difference between the sexes, nor between
those living in the inner city and suburbs, either before or
after adjustment for age. Round 2 non-responders were also
more likely than responders to have had SKs/NMSCs
detected in round 1, an association that was not independent
of age on multiple logistic regression analysis.
Slide validation of diagnoses
The majority view of the three validating consultant
dermatologists was taken as the 'gold standard'. Altogether,
160 randomly selected slides were shown. Crude agreement
was 86.3% (138/160). A total of 135/154 SKs diagnosed by
the researcher were confirmed as SKs by the panel [predictive
value= 87.7% (95% confidence interval 83-93%]. The
validators diagnosed 137 SKs in total [89% (95% CI 84-
94%) of the number diagnosed by the researcher].
Demographic characteristics ofstudy subjects
These are shown in Table I. The mean (median) age when
first seen in the study was 71.2 (69.3) years.
Skin, pigmentation and UV exposure characteristics ofsubjects
The main results are shown in Table II. Subjects were asked
about their skin type, hair colour at age 15 and their
cumulative lifetime exposure to outdoor conditions at both
visits. On the second occasion the researcher was blind to the
response given on the first. For skin type, crude agreement
was 61% (Cohen's kappa = 0.43). For UV exposure (divided
into quintiles), crude agreement was 37%, and 79% of
subjects lay within one quintile of their round 1 assessment
(Cohen's kappa = 0.21). For hair colour crude agreement was
63% (Cohen's kappa=0.52).
Some 43% (241/560, 95% CI 39-47%) of subjects either
never tan or tan with difficulty. Mean (median) cumulative
3
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UV exposure was 59 450 (54 450) h, equivalent to a mean of
2.3 h exposure per day during the lifetime of a study
participant of mean age (71.2 years). A total of 3.8% (21/
560, 95% CI 2.3-5.7%) of subjects reported sunburn during
the previous 2 years and 4.8% (27/559, 95% CI 3.2-7.0%)
were current users of sunbeds or UV lamps. Of the total,
34% (188/560, 95% CI 30-38%) claimed to use sunscreen
regularly.
Descriptive epidemiology
Solar keratoses The principal findings are shown in Table
III. The crude prevalence of solar keratoses was 23% (129/
560) at the first examination (95% CI 19.5-26.5%), with a
median of two SKs per person (range 1-17). Of these 31%
were on the head and neck and 44% on the forearms. Age/
sex-specific prevalence of SKs is shown in Table IV. Some
12.6% of subjects (49/390, 95% CI 9.3-15.9%) developed at
least one new SK during the follow-up period.
A total of 557 person-years offollow-up were available in
the study. The incidence of new SKs during the follow-up
period was 149 per 1000 person-years (95% CI 119-178).
Considering the number of persons affected by new SKs
(rather than the number of new lesions) the incidence was 88
newly affected individuals per 1000 person-years (95% CI
63-113).
Twenty-one per cent (50/239, 95% CI 16-26%) of SKs
present at the first visit regressed spontaneously by the time
of the second visit. A total of 334 solar keratosis-years of
observation were available from the study (assuming that SK
regression occurred on average halfway through the follow-
up period), which provides the denominator for calculation
of the following rates. The SK regression rate is 150 per
1000 SKs per year (95% CI 111-188). None underwent
malignant change. This permits 95% confidence that the true
rate of malignant transformation of SKs lies between 0 and
11 per 1000 SKs per year.
Table II Skin, pigmentation and ultraviolet exposure characteristics
of subjects
Variable
Skin
pigmentation
Skin type
(reaction to
sun)
Eye colour
Cumulative
sun exposure
(h)
Sunburn
during the
last 2 years
Current use
of sunbeds/
sunlamps
Categories
Negro/Asian
Dark
Medium
Fair
Never tans, always burns
Tans with difficulty
burns easily
Tans easily, burns rarely
Always tans, never burns
Genetically brown
Genetically black
Blue/green
Brown/grey
0-29 999
30 000-49 999
50 000-69 999
70 000-89 999
90 000-109 999
110 000+
Yes
No
Yes
No
Numbers
5
23
279
253
46
195
237
76
3
2
386
174
32
198
185
79
38
28
Percentages
0.9
4.1
49.8
45.2
8.2
34.9
42.4
13.6
0.5
0.4
69
31
5.7
35.4
33.0
14.1
6.8
5.0
21 3.8
539 96.2
27 4.9
532 95.1
medical attention and all had their lesions histologically
verified. The incidence rate ofnew NMSCs was therefore 8.98
per 1000 person-years (95% CI 2.9-20.8) and there were no
new MMs (95% CI 0-6.6 per 1000 person-years).
Skin cancer The prevalence of NMSC was 1.6% (9/560,
95% CI 0.74-3.0%) with a basal cell to squamous cell ratio
of 8: 1. Of these, 0.36% (2/560, 95% CI 0.043-1.29%) had
malignant melanoma. Histological confirmation was available
for 8/11 of the subjects with clinically diagnosed skin cancer
in round 1. No lesions other than prevalent lesions identified
during the first visit were removed by either dermatologists or
GPs during the follow-up interval.
At the follow-up visit five subjects were clinically judged to
have developed new skin cancers, in all cases NMSC (basal
cell carcinomata). Three subjects subsequently attended for
Table I Demographic characteristics of study subjects
Variable Categories Number Percentage
Age (years) 60-64 138 25
65-69 159 28
70-74 90 16
75-79 92 16
80+ 81 15
Sex Male 234 42
Female 326 58
Social class I 41 7.3
II 125 22.4
III non-manual 95 17.0
III manual 170 30.4
IV 87 15.6
V 31 5.5
Unclassifiable 10 1.7
Marital status Married 324 58
Single 35 6.3
Divorced/separated 15 2.7
Widowed 185 33.1
Discussion
Skin cancer, allowing for under-registration, is probably the
most commonly occurring cancer in Britain (Harvey et al.,
1989) and its incidence is generally agreed to be rising. It is
no exaggeration to think of this as an epidemic (an
occurrence in excess of expectation), although this terminol-
ogy is more usually found in Australian descriptions of the
problem (Marks, 1987). Recognising the magnitude of the
threat to the public health, the UK government health
strategy, The Health of the Nation, has proposed the
ambitious target of halting the increase in incidence in the
UK of all types of skin cancer by the year 2005 (Anonymous,
1993). Target setting is the simplest part, however, of a more
complex process. It is clear in the case of skin cancer that
important issues remain unaddressed concerning both the
data requirements to monitor progress towards this target
and the effectiveness of many of the preventive measures that
are at present being widely implemented (Melia et al., 1994).
The South Wales study reported here is intended to
contribute to both these areas.
Certain methodological matters require comment. The age
group chosen for this study and the areas of the body
examined were based upon the known sharp increase in
prevalence and incidence of SKs and NMSCs over age 60
and the known anatomical distribution of the lesions (Scotto
and Fears, 1978). The proportion of subjects in the random
sample who were not available owing to change of address or
death (23.4%) is similar to that found by Bickler and Sutton
(1993) in inner London (26.7%), but higher than that
reported (Roberts et al., 1995) from Nottingham (up to
8.7%). It is likely that accuracy of FHSA registers has
improved significantly since our study was performed as a
result of efforts to improve their validity. The response rates
were broadly comparable with other studies undertaken in
this age group (Marshall, 1987), but it is clear that theNMSC and Solar keratoses in the UK
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Table III Prevalence and incidence rates of skin lesions
Measure of Point estimate (95%
Type oflesion frequency confidence limits)
Solar keratoses Prevalence 129/560=23% (19.5-26.5)
Basal cell carcinoma Prevalence 8/560 = 1.4% (0.6-2.8)
Squamous cell carcinoma Prevalence 1/560=0.2% (0.006-1.0)
Malignant melanoma Prevalence 2/560=0.4% (0.04-1.3)
Solar keratoses: new lesions Incidence (lesion-based)a 83 new SKs = 149/1000
person-years (119- 178)
Solar keratoses: new lesions Incidence (person-based)b 49 subjects= 88/1000
person-years (63 -113)
Solar keratoses: regression Regression rate 50 SKs regressed= 150/1000
SKs per year (111-188)
Solar Keratoses: malignant change Transformation rate Zero SKs transformed=
0/1000 SKs per year (0-11)
Basal cell carcinoma: new lesions Incidence rate 5 new lesions=8.98/1000
person-years (2.9-20.8)
Squamous cell carcinoma: new lesions Incidence rate No new lesions=0/1000
person -years (0-6.6)
Malignant melanoma: new lesions Incidence rate No new lesions=0/1000
person-years (0 -6.6)
aIncidence based upon number of new lesions. bIncidence based upon number of subjects affected by new
lesions.
Table IV Age/sex-specific prevalence of solar keratoses
Age group Prevalence of SKs
(years) % (denominator)
Male 60-64 17 (58)
65-69 24 (72)
70-74 35 (37)
75-79 50 (42)
80+ 64 (25)a
Female 60-64 10 (80)
65-69 6 (87)
70-74 25 (53)
75-79 26 (50)
80+ 23 (56)
aChi-square test forlineartrend: P< 0.001.bChi-square testforlinear
trend: P< 0.000001.
tendency of older subjects not to participate is likely to bias
the results in the direction of generally lower prevalence and
incidence rate estimates. This is particularly so for the follow-
up visit, where only 56% of the originally eligible subjects
agreed to be examined.
Histological confirmation was available for the majority of
NMSCs diagnosed in this study, as has been widely
recommended (Green et al., 1988; Nixon et al., 1986). The
proportion of subjects for whom histology was available (8/
11) is similar to the reported proportion of subjects with
suspicious lesions attending for definitive diagnosis as part of
skin cancer screening programmes (Krol et al., 1991).
Australian evidence indicates that, in the case of SKs, a
clinical diagnosis arrived at by experienced dermatologists is
confirmed in 94% of cases by histology (Ponsford et al.,
1983), rendering histological confirmation of these lesions less
important. The agreement in diagnosis of SKs between the
research registrar and the panel of validating dermatologists
in this study (86%) was satisfactory. One limitation, however,
is that the photographic validation only allowed assessment
of the positive predictive value (the proportion diagnosed as
SK actually having SK) of a diagnosis of SK. The negative
predictive value (the proportion diagnosed as not having SK
who truly do not), which should ideally be 100%, cannot be
assessed from the data collected.
Many of the key exposure variables in this study consisted
ofself-reported data of a type which are inherently difficult to
validate. Nonetheless, there are good grounds for using this
approach. Cumulative sun exposure was assessed using
methods used in several previous studies (Vitasa et al.,
1990; Gafa et al., 1991; Urbach and Vitaliano, 1980). The
test-retest reliability between the first round and follow-up
visit (with 79% of subjects within one quintile of their earlier
response) was acceptable for epidemiological purposes,
although the kappa value (0.21) was in the zone denoting
relatively poor agreement. Self-assessed skin type, for which
the kappa value (0.43) indicates moderate reliability, has been
shown to correlate well with the gold standard of measured
minimal erythema dose (MED) (Weinstock, 1992).
Turning to the substantive results, almost a quarter of
subjects had at least one solar keratosis at baseline and one in
eight developed at least one new solar keratosis during the
follow-up period. One in fifty subjects had an undiagnosed
skin cancer (either NMSC or MM) during the prevalence
round and just under 1% developed a new NMSC per annum
of follow up.
A clearer appreciation ofthese descriptive findings emerges
from comparison with international data (Frost and Green,
1994). In Australia two large studies have indicated a
prevalence of SKs in those over 40 years of between 38%
(Goodman et al., 1984) and 57% (Marks et al., 1983). From
the United States, SK prevalences of 16% (in those over 21
years) (Zagula-Malley et al., 1974) and 10% (65-74 year
olds) (Johnson and Roberts, 1978) have been reported. The
only previous population-based study from North-West
Europe revealed a prevalence of SKs among those over 60
years of 24% (O'Beirn et al., 1968), but had wide confidence
limits.
Reported prevalence of NMSC has ranged from 2-3%
(Goodman et al., 1984; Marks et al., 1983) (over 40 years) in
Australia to 3.6% (65-74 years) (Johnson and Roberts,
1978) in the USA and a histologically verified prevalence of
2% (O'Beirn et al., 1968) (over 60 years) in the west of
Ireland, again with wide confidence limits. Age-specific
incidence rates for NMSC from an Australian population-
based study have been 23/1000 per year (60-69-year-olds)
and 50/1000 per year (70-year-olds and above) (Marks et al.,
1989).
It is clear from these comparisons that, although generally
less common than in sunnier climates like that of Australia
and the southern USA, the prevalence and incidence of SKs
and NMSCs in this UK random population sample is at a
level denoting major clinical and public health significance. In
terms of the relative emphases placed upon NMSC and MM
it is, moreover, likely that health care expenditure on NMSC
is actually greater (Maize, 1986). Interest should not therefore
focus upon malignant melanoma to the detriment of NMSC,
as has tended to occur in this country.MC d Sdw br in do UK $W306 Havey et a
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The natural history of solar keratoses is of particular
importance because of the considerable resources devoted
worldwide to their obliteration. As with other pre-malignant
lesions, such as those of the cervix, our understanding of
their natural history is relatively poor. Spontaneous remission
of SKs has only been quantified in one other longitudinal
study (Marks et al., 1986), in Australia, in which 10% of SKs
regressed over a one year period, compared with an
annualised proportion of 15% in this study. The same
Australian study has also estimated the rate of malignant
transformation of SKs as 0.75/1000 SK per year (Marks et
al., 1988), again consistent with the rate of 0/1000 SK per
year (95% CI 0-11) found in this study. The combination of
a high spontaneous regression and low malignant transforma-
tion rate in studies in two countries raises a major question
mark over the wisdom of assiduously treating all detected
SKs (Marks, 1991).
Finally, this study presents evidence concerning the sun
and ultraviolet exposure behaviour of this elderly population.
The findings invite comparison with those of the 1993 and
1994 Omnibus Surveys undertaken in the UK by the Office of
Population Censuses and Surveys (OPCS). Reported use of
sunbeds/UV lamps was significantly higher in this study than
that reported in the 1994 survey for the age group 55 years
and over (1.1%) (Anonymous, 1994). This may indicate a
recent decline in sunbed use as a result of increasing
knowledge of their potential hazards, but could equally
reflect geographical variation and/or differences in ascertain-
ment. The period prevalence of sunburn in this study is
similar to that found in the 1993 OPCS Omnibus survey for
this age group (Melia and Bulman, 1995).
Other findings, principally the analytical epidemiological
results and an evaluation of preventive measures including
sunscreen use, will be presented in a companion paper
(Harvey et al., 1996). These descriptive findings provide
important baseline data, comparison with which will allow, in
due course, an overall evaluation of the current programme
of primary skin cancer prevention in the UK.
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